{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:32:13Z","timestamp":1790040733432,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T00:00:00Z","timestamp":1466985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/aps.2016.59","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T09:10:26Z","timestamp":1467018626000},"page":"1121-1128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dendritic cells serve as a \u201cTrojan horse\u201d for oncolytic adenovirus delivery in the treatment of mouse prostate cancer"],"prefix":"10.1038","volume":"37","author":[{"given":"Zhao-lun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,27]]},"reference":[{"key":"BFaps201659_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"BFaps201659_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0302-2838(02)00505-5","volume":"43","author":"B Djavan","year":"2003","unstructured":"Djavan B, Moul JW, Zlotta A, Remzi M, Ravery V . PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium. Eur Urol 2003; 43: 12\u201327.","journal-title":"Eur Urol"},{"key":"BFaps201659_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1530\/ERC-14-0267","volume":"21","author":"V Jeet","year":"2014","unstructured":"Jeet V, Tevz G, Lehman M, Hollier B, Nelson C . Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. Endocr Relat Cancer 2014; 21: 723\u201337.","journal-title":"Endocr Relat Cancer"},{"key":"BFaps201659_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/hum.2009.206","volume":"21","author":"E Schenk","year":"2010","unstructured":"Schenk E, Essand M, Bangma CH, Barber C, Behr JP, Briggs S, et al. Clinical adenoviral gene therapy for prostate cancer. Hum Gene Ther 2010; 21: 807\u201313.","journal-title":"Hum Gene Ther"},{"key":"BFaps201659_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.cgt.7700881","volume":"13","author":"WS Cheng","year":"2006","unstructured":"Cheng WS, Dzojic H, Nilsson B, Totterman TH, Essand M . An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer. Cancer Gene Ther 2006; 13: 13\u201320.","journal-title":"Cancer Gene Ther"},{"key":"BFaps201659_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gt.2009.29","volume":"16","author":"EJ Ilett","year":"2009","unstructured":"Ilett EJ, Prestwich RJ, Kottke T, Errington F, Thompson JM, Harrington KJ, et al. Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene Ther 2009; 16: 689\u201399.","journal-title":"Gene Ther"},{"key":"BFaps201659_CR7","doi-asserted-by":"publisher","first-page":"e1004541","DOI":"10.1371\/journal.ppat.1004541","volume":"10","author":"MA Schmid","year":"2014","unstructured":"Schmid MA, Harris E . Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog 2014; 10: e1004541.","journal-title":"PLoS Pathog"},{"key":"BFaps201659_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11684-011-0172-4","volume":"5","author":"H Xu","year":"2011","unstructured":"Xu H, Cao X . Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine. Front Med 2011; 5: 323\u201332.","journal-title":"Front Med"},{"key":"BFaps201659_CR9","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1084\/jem.191.11.2011","volume":"191","author":"AM Moodycliffe","year":"2000","unstructured":"Moodycliffe AM, Shreedhar V, Ullrich SE, Walterscheid J, Bucana C, Kripke ML, et al. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 2000; 191: 2011\u201320.","journal-title":"J Exp Med"},{"key":"BFaps201659_CR10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1158\/0008-5472.CAN-11-3001","volume":"72","author":"S Pesonen","year":"2012","unstructured":"Pesonen S, Diaconu I, Kangasniemi L, Ranki T, Kanerva A, Pesonen SK, et al. Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients. Cancer Res 2012; 72: 1621\u201331.","journal-title":"Cancer Res"},{"key":"BFaps201659_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0960-0760(95)00001-G","volume":"52","author":"PA Baley","year":"1995","unstructured":"Baley PA, Yoshida K, Qian W, Sehgal I, Thompson TC . Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer. J Steroid Biochem Mol Biol 1995; 52: 403\u201313.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFaps201659_CR12","doi-asserted-by":"publisher","first-page":"e46981","DOI":"10.1371\/journal.pone.0046981","volume":"7","author":"BJ Williams","year":"2012","unstructured":"Williams BJ, Bhatia S, Adams LK, Boling S, Carroll JL, Li XL, et al. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector. PLoS One 2012; 7: e46981.","journal-title":"PLoS One"},{"key":"BFaps201659_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/14653240600845278","volume":"8","author":"Z Yan","year":"2006","unstructured":"Yan Z, Zhao N, Wang Z, Li B, Bao C, Shi J, et al. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo. Cytotherapy 2006; 8: 415\u201323.","journal-title":"Cytotherapy"},{"key":"BFaps201659_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/mt.2009.205","volume":"18","author":"JH Huang","year":"2010","unstructured":"Huang JH, Zhang SN, Choi KJ, Choi IK, Kim JH, Lee MG, et al. Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL. Mol Ther 2010; 18: 264\u201374.","journal-title":"Mol Ther"},{"key":"BFaps201659_CR15","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4049\/jimmunol.1101443","volume":"187","author":"H Wu","year":"2011","unstructured":"Wu H, Kumar A, Miao H, Holden-Wiltse J, Mosmann TR, Livingstone AM, et al. Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors. J Immunol 2011; 187: 4474\u201382.","journal-title":"J Immunol"},{"key":"BFaps201659_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1189\/jlb.0408241","volume":"85","author":"B Liu","year":"2009","unstructured":"Liu B, Woltman AM, Janssen HL, Boonstra A . Modulation of dendritic cell function by persistent viruses. J Leukoc Biol 2009; 85: 205\u201314.","journal-title":"J Leukoc Biol"},{"key":"BFaps201659_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2217\/epi.13.14","volume":"5","author":"HP Kim","year":"2013","unstructured":"Kim HP, Lee YS, Park JH, Kim YJ . Transcriptional and epigenetic networks in the development and maturation of dendritic cells. Epigenomics 2013; 5: 195\u2013204.","journal-title":"Epigenomics"},{"key":"BFaps201659_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.eururo.2009.07.027","volume":"57","author":"T Wolters","year":"2010","unstructured":"Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, et al. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol 2010; 57: 821\u20139.","journal-title":"Eur Urol"},{"key":"BFaps201659_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.v16.i1.10","volume":"16","author":"MH Bemelmans","year":"1996","unstructured":"Bemelmans MH, van Tits LJ, Buurman WA . Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 1996; 16: 1\u201311.","journal-title":"Crit Rev Immunol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201659","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:34:42Z","timestamp":1684413282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,27]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFaps201659"],"URL":"https:\/\/doi.org\/10.1038\/aps.2016.59","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,27]]},"assertion":[{"value":"19 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}